Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

Biotechnology

Healthcare
$7.46 +1.16%

+$0.05 today

Market cap
$587.14M
Beta
0.50
P/E (TTM)
-2.8
EPS (TTM)
-$1.42
52W Low $2.20High $5.42

Volume 1.20M

Average 0.22M

Price history

Orchestra BioMed Holdings, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+60.09%

Period high

$7.46

Period low

$3.49

Latest

$7.46

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13D/ANov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
10-QNov 10, 2026Nov 10, 2026
4Nov 9, 2026Nov 9, 2026
4Nov 9, 2026Nov 9, 2026
4Nov 9, 2026Nov 9, 2026
4Nov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
424B5Nov 6, 2026Nov 6, 2026
424B5Nov 5, 2026Nov 5, 2026
4Nov 3, 2026Nov 3, 2026
4Oct 2, 2026Oct 2, 2026
8-KOct 1, 2026Oct 1, 2026
4Sep 11, 2026Sep 11, 2026
4Sep 8, 2026Sep 8, 2026

Competitors

Who does Orchestra BioMed Holdings, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about OBIO's filings, answered from its disclosures.

What is the latest OBIO filing?

The latest filing shown is SC 13D/A dated Nov 12, 2026.

How many recent filings does OBIO have?

Intrinsic Alpha currently shows 20 recent filings for OBIO.